17Oct
Robeco Institutional Asset Management BV Purchases New Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Robeco Institutional Asset Management BV purchased a new stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Get Rating) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 2,594 shares of the company’s stock, valued at approximately $280,000.

Several other institutional investors and hedge funds have also made changes to their positions in the IRTC. FNY Investment Advisers LLC acquired a new stake in iRhythm Technologies in the first quarter worth $55,000. CIBC Asset Management Inc acquired a new stake in iRhythm Technologies in the first quarter worth $216,000. Xponance Inc. acquired a new stake in iRhythm Technologies in the first quarter worth $222,000. Pearl River Capital LLC acquired a new stake in iRhythm Technologies in the first quarter worth $232,000. Finally, Bluestein RH & Co. LLC acquired a new stake in iRhythm Technologies in the first quarter worth $236,000. 98.98% of the stock is owned by institutional investors and hedge funds.

iRhythm Technologies Trading Down 2.1%

NASDAQ:IRTC opened at $116.46 on Monday. The company has a quick ratio of 3.84, a current ratio of 4.04 and a debt-to-equity ratio of 0.14. iRhythm Technologies, Inc. has a 1-year low of $66.85 and a 1-year high of $169.54. The firm

…
15Oct
Allspring Global Investments Holdings LLC Has $10.66 Million Stock Position in Keysight Technologies, Inc. (NYSE:KEYS)

Allspring Global Investments Holdings LLC trimmed its position in Keysight Technologies, Inc. (NYSE:KEYS – Get Rating) by 15.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,328 shares of the scientific and technical instruments company’s stock after selling 14,625 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Keysight Technologies were worth $10,658,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Geneos Wealth Management Inc. lifted its stake in shares of Keysight Technologies by 37.1% in the second quarter. Geneos Wealth Management Inc. now owns 277 shares of the scientific and technical instruments company’s stock worth $37,000 after buying an additional 75 shares during the last quarter. Los Angeles Capital Management LLC lifted its stake in shares of Keysight Technologies by 2.8% in the first quarter. Los Angeles Capital Management LLC now owns 2,859 shares of the scientific and technical instruments company’s stock worth $452,000 after buying an additional 77 shares during the last quarter. TCI Wealth Advisors Inc. lifted its stake in shares

…
3Oct
Ellevest Inc. Acquires 209 Shares of Minerals Technologies Inc. (NYSE:MTX)

Ellevest Inc. boosted its holdings in Minerals Technologies Inc. (NYSE:MTX – Get Rating) by 74.9% in the second quarter, HoldingsChannel reports. The firm owned 488 shares of the basic materials company’s stock after purchasing an additional 209 shares during the period. Ellevest Inc.’s holdings in Minerals Technologies were worth $30,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in MTX. Ethic Inc. acquired a new stake in Minerals Technologies in the first quarter valued at approximately $203,000. Verdence Capital Advisors LLC grew its stake in Minerals Technologies by 6.2% in the first quarter. Verdence Capital Advisors LLC now owns 3,532 shares of the basic materials company’s stock valued at $234,000 after acquiring an additional 207 shares during the period. Inspire Investing LLC acquired a new stake in Minerals Technologies in the first quarter valued at approximately $282,000. Mercer Global Advisors Inc. ADV grew its stake in Minerals Technologies by 60.4% in the first quarter. Mercer Global Advisors Inc. ADV now owns 4,773 shares of the basic materials company’s stock valued at $316,000 after acquiring an additional 1,797 shares during the period. Finally, SG Americas Securities LLC

…
12Sep
Roper Technologies, Inc. (NYSE:ROP) Stock Holdings Lowered by Hsbc Holdings PLC

Hsbc Holdings PLC trimmed its holdings in shares of Roper Technologies, Inc. (NYSE:ROP – Get Rating) by 31.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 109,639 shares of the industrial products company’s stock after selling 49,270 shares during the period. Hsbc Holdings PLC’s holdings in Roper Technologies were worth $52,019,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ROP. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in shares of Roper Technologies during the 1st quarter valued at $28,000. Curi Wealth Management LLC lifted its holdings in shares of Roper Technologies by 1,625.0% during the first quarter. Steal Wealth Management LLC now owns 69 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 65 shares during the last quarter. Quent Capital LLC acquired a new position in shares of Roper Technologies in the 4th quarter valued at $44,000. Kempen Capital Management NV purchased a new position in Roper Technologies in the 1st quarter worth about $43,000. Finally, Jones Financial Companies Lllp raised its holdings in Roper Technologies

…
19Aug
Agilent Applied sciences, Inc. to Publish FY2022 Earnings of $5.07 Per Share, SVB Leerink Forecasts (NYSE:A)

Agilent Applied sciences, Inc. (NYSE:A – Get Score) – Analysis analysts at SVB Leerink lifted their FY2022 EPS estimates for Agilent Applied sciences in a analysis report issued to purchasers and buyers on Tuesday, August sixteenth. SVB Leerink analyst P. Souda now forecasts that the medical analysis firm will put up earnings per share of $5.07 for the 12 months, up from their earlier estimate of $4.91. The consensus estimate for Agilent Applied sciences’ present full-year earnings is $4.88 per share. SVB Leerink additionally issued estimates for Agilent Applied sciences’ This autumn 2022 earnings at $1.38 EPS, Q1 2023 earnings at $1.32 EPS, Q2 2023 earnings at $1.26 EPS, Q3 2023 earnings at $1.37 EPS, This autumn 2023 earnings at $1.42 EPS, FY2023 earnings at $5.37 EPS, Q1 2024 earnings at $1.44 EPS, Q2 2024 earnings at $1.37 EPS, Q3 2024 earnings at $1.49 EPS and FY2024 earnings at $5.83 EPS.

Agilent Applied sciences (NYSE:A – Get Score) final issued its quarterly earnings knowledge on Tuesday, August sixteenth. The medical analysis firm reported $1.34 EPS for the quarter, topping the consensus estimate of $1.20 by $0.14. Agilent Applied sciences had a return on fairness of 28.29% and a web margin

…
13Aug
Is It Time To Think about Shopping for Volpara Well being Applied sciences Restricted (ASX:VHT)?

Volpara Well being Applied sciences Restricted (ASX:VHT), won’t be a big cap inventory, nevertheless it led the ASX gainers with a comparatively giant value hike prior to now couple of weeks. With many analysts protecting the inventory, we might count on any price-sensitive bulletins have already been factored into the inventory’s share value. Nevertheless, may the inventory nonetheless be buying and selling at a comparatively low cost value? Right this moment I’ll analyze the latest knowledge on Volpara Well being Applied sciences’ outlook and valuation to see if the chance nonetheless exists.

See our newest evaluation for Volpara Well being Applied sciences

Is Volpara Well being Applied sciences Nonetheless Low-cost?

Nice information for buyers – Volpara Well being Applied sciences remains to be buying and selling at a reasonably low cost value. My valuation mannequin reveals that the intrinsic worth for the inventory is A$1.15, however it’s at the moment buying and selling at AU$0.70 on the share market, which means that there’s nonetheless a chance to purchase now. Nevertheless, on condition that Volpara Well being Applied sciences’ share is pretty risky (ie its value actions are magnified relative to the remainder of the market) this might imply the worth

…
25Jul
Canadians who received pandemic pets say they’ve skilled psychological well being advantages

Spike was a tiny pet, virtually sufficiently small to slot in one hand, when Laurie Brooke introduced him house in Could 2021, however he had an unlimited influence on her life from the second he arrived.

Even earlier than the pandemic, Brooke struggled with melancholy and nervousness, and he or she found having Spike was an excellent addition to her common remedy.

“He is like a instrument in my psychological well being toolbox,” stated Brooke, who lives in Toronto.

Simply holding the little Yorkshire terrier and searching into his eyes helped her to focus and be within the second when she was feeling careworn.

“He simply jogs my memory to be current, to be right here to be with him, to be glad.”

Spike additionally helped her with social nervousness. Whereas enjoying fetch, he would carry the ball to strangers to throw for him, forcing Brooke to work together with different folks.

It was an identical expertise for Andrea Kovacs, who received her pet Violet, a golden retriever, after transferring from Burlington, Ont., to North Vancouver in the course of the pandemic.

Woman poses with dog.
Andrea Kovacs, who moved from Burlington, Ont., to Vancouver, says her golden retriever Violet helped her see the
…
14Jul
Keto versus Mediterranean weight reduction program: Which gained?

A model new managed medical trial accomplished by the pandemic in distinction the two diets by asking 33 of us with prediabetes or diabetes to do every diets, one after the other, for 3 months. By the primary 4 weeks of each weight reduction program, contributors acquired each healthful keto- or Mediterranean-based meal deliveries, then adopted meal plans on their very personal.

Researchers monitored contributors’ weight, blood sugar (glucose) ranges, cardiovascular hazard parts and adherence to the load loss program. Which weight reduction program was nonetheless standing on the closing bell?

“Every diets improved blood glucose administration to the identical diploma, and every groups misplaced an identical quantity of weight,” talked about important vitamin researcher Dr. Walter Willett, a professor of epidemiology and vitamin at Harvard TH Chan School of Public Properly being and professor of remedy at Harvard Medical School. He was not involved inside the study.

Nonetheless, when researchers examined the affect of the two diets on ranges of blood fats that contribute to coronary coronary heart sickness, the Mediterranean weight reduction program was the clear winner, in accordance with the study printed Friday in The American Journal of Scientific Food regimen.

The study tracked low-density lipoprotein, or

…